- Home
- BNTC vs TECX Comparison
BNTC vs TECX Comparison
Compare BNTC & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- TECX
- Stock Information
- Founded
- BNTC 1995
- TECX 2019
- Country
- BNTC United States
- TECX United States
- Employees
- BNTC N/A
- TECX N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- TECX
- Sector
- BNTC Health Care
- TECX
- Exchange
- BNTC Nasdaq
- TECX Nasdaq
- Market Cap
- BNTC 335.5M
- TECX 387.1M
- IPO Year
- BNTC N/A
- TECX 2018
- Fundamental
- Price
- BNTC $12.99
- TECX $26.18
- Analyst Decision
- BNTC Strong Buy
- TECX Strong Buy
- Analyst Count
- BNTC 5
- TECX 5
- Target Price
- BNTC $26.00
- TECX $79.00
- AVG Volume (30 Days)
- BNTC 41.1K
- TECX 226.1K
- Earning Date
- BNTC 09-25-2025
- TECX 08-07-2025
- Dividend Yield
- BNTC N/A
- TECX N/A
- EPS Growth
- BNTC N/A
- TECX N/A
- EPS
- BNTC N/A
- TECX N/A
- Revenue
- BNTC N/A
- TECX N/A
- Revenue This Year
- BNTC N/A
- TECX N/A
- Revenue Next Year
- BNTC N/A
- TECX N/A
- P/E Ratio
- BNTC N/A
- TECX N/A
- Revenue Growth
- BNTC N/A
- TECX N/A
- 52 Week Low
- BNTC $8.06
- TECX $13.70
- 52 Week High
- BNTC $17.15
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- BNTC 58.50
- TECX 65.02
- Support Level
- BNTC $12.04
- TECX $23.42
- Resistance Level
- BNTC $13.09
- TECX $24.89
- Average True Range (ATR)
- BNTC 0.63
- TECX 1.63
- MACD
- BNTC 0.18
- TECX 0.33
- Stochastic Oscillator
- BNTC 93.47
- TECX 99.20
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.